Latest Breaking News On - பரிவாரங்கள் விளைவு மூலதனம் - Page 5 : comparemela.com

Press release content from Business Wire. The AP news staff was not involved in its creation. CURE Pharmaceutical Announces Promotions and Additions to Board of Directors February 11, 2021 GMT OXNARD, Calif. (BUSINESS WIRE) Feb 11, 2021 CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, announced today updates and additions to its Board of Directors. ADVERTISEMENT After a dedicated run as Chairman of the Board, William Yuan is stepping down and will continue to serve the Company as an advisor and Chairman Emeritus. Rubén José King-Shaw Jr, a highly qualified and respected member of the Board, has been selected to step into that role. Mr. King-Shaw brings with him three decades of executive leadership experience in the healthcare technology and private equity sectors. He recently served on the board of Atlanta-based Cotiviti Holdings, Inc. an

United statesKathryn brownGeorgew bushGary zwetchkenbaumRob davidsonKing shaw jrMexican stock exchangeSteward health care systemsCotiviti holdings incWellcare health plans incOversight committeeHealth planHolding corpNeighborhood health partnership incDeputy administrator of the centers for medicareObama administration medicare program advisory